TNNT2 and coronary artery disorder: MACEs occurred in 5 (9.3%) patients in the NCA and normal hs-cTnT group, 2 (8.7%) patients in the CAD and normal hs-cTnT group, 7 (13.2%) patients in the NCA and elevated hs-cTnT group, and 10 (31.3%) patients in the CAD and elevated hs-cTnT group.